BioSniper
ZH
Toggle language
Open menu
Patent Expiry
Patent/Exclusivity Expiry: APADAZ
February 22, 2031
Company
ZEVRA THERAPEUTICS, INC. (ZVRA)
Drug
APADAZ
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.
Start Free
Full Calendar
ZVRA Overview
PDUFA Dates
Phase 3 Readouts
Patent/Exclusivity Expiry: APADAZ — ZVRA Patent Expiry | BioSniper